Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 26, 2011
Sigma-Aldrich Corporation today announced that its custom manufacturing and services business unit, SAFC® (www.safcglobal.com), has completed an assessment by SafeBridge® Consultants, Inc. and has been granted SafeBridge Certification for its ...
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, recently enhanced their web based randomization system WebEZ™, and are relauching the product under the new name, aXcess™. aXcess™ includes similar ...
read more
GSK today confirmed that it will invest more than £500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines. The company announced selection of Ulverston in Cumbria ...
read more
Albany, NY (April 3, 2012)–AMRI (Nasdaq: AMRI), a global contract healthcare services organization spanning the entire R&D continuum, announced today that it has signed an exclusive option to enter a license agreement with Bessor Pharma, LLC a ...
read more
Wednesday, April 04, 2012
Somerset, NJ and Ludwigshafen, Germany – April 4, 2012 – Catalent Pharma Solutions and BASF have entered into a broad collaboration and Open Alliance to provide solutions to overcome bioavailability challenges of new molecular entities with ...
read more
After acquiring Cognis in 2011, BASF has significantly expanded its range of solubilization and dermatology excipients. The new dermatology and solubilization portfolios, launched on April 1, 2012, offer a wide range of innovative pharmaceutical-...
read more
Richman Chemical Inc. (RCI), a custom synthesis, chemical manufacturing, and raw materials sourcing provider to the life science and chemical industries, announces a new partnership with Auditweaver, LLC., a specialty consultancy firm to the life ...
read more
EMD Millipore, the Life Science division of Merck KGaA of Germany, announced today that it will host the third annual EMD Millipore Pharma Forum on June 12, 2012, at the company’s headquarters in Darmstadt, Germany. The event will bring together ...
read more
Wednesday, April 25, 2012
AAIPharma Services Corp., a leading provider of product-development services for the pharmaceutical industry, today officially opens a 40,000 square foot, state-of-the-art Technology Center on its Wilmington, N.C., headquarters campus as part of a $...
read more
Almac has been recognised for its cutting edge technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (bmi).
read more
This year the GEA Pharma Systems stand at ACHEMA will include the company’s wide range of specialist equipment for processing highly potent compounds providing the highest yields and levels of operator and environmental protection available.
read more
Dr. Parks, currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM N.V. (NYSE, Euronext: DSM KON), has been appointed President and Business Unit Director of DSM Pharmaceuticals, Inc, as of...
read more
PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that industry veteran ...
read more
Aceto Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generic pharmaceuticals, nutraceutical products, agricultural protection products ...
read more